| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CAI
Caris Life Sciences, Inc.
|
Jul 02, 2026 | BUY |
Strong Buy
+63.4% avg upside
20 analysts
|
$32.00
88.47% Upside
|
-7.2% |
|
GH
Guardant Health
|
Jul 01, 2026 | BUY |
Strong Buy
-10.3% avg upside
31 analysts
|
$190.00
19.00% Upside
|
-5.4% |
|
NTRA
Natera
|
Jun 23, 2026 | BUY |
Strong Buy
-4.3% avg upside
26 analysts
|
$270.00
0.89% Downside
|
+16.1% |
|
SOPH
SOPHiA GENETICS
|
Jun 15, 2026 | BUY |
Strong Buy
+69.2% avg upside
7 analysts
|
$8.00
40.56% Upside
|
-5.7% |
|
TEM
Tempus AI, Inc. Class A
|
Jun 01, 2026 | BUY |
Strong Buy
+16.2% avg upside
20 analysts
|
$80.00
37.21% Upside
|
+11.1% |
|
IMDX
Insight Molecular Diagnostics
|
May 15, 2026 | HOLD |
Buy
+19.7% avg upside
10 analysts
|
— | · |
|
LUCD
Lucid Diagnostics
|
May 15, 2026 | BUY |
Strong Buy
+385.0% avg upside
8 analysts
|
$2.50
149.91% Upside
|
-2.1% |
|
TKNO
Alpha Teknova
|
May 14, 2026 | HOLD |
Strong Buy
+164.9% avg upside
7 analysts
|
— | +39.2% |
|
MDXH
MDxHealth
|
May 13, 2026 | BUY |
Strong Buy
+1421.5% avg upside
8 analysts
|
$4.00
863.68% Upside
|
-75.6% |
|
CSTL
Castle Biosciences
|
May 13, 2026 | BUY |
Strong Buy
+80.0% avg upside
9 analysts
|
$40.00
73.96% Upside
|
+27.4% |
|
MXCT
MaxCyte
|
May 13, 2026 | HOLD |
Strong Buy
+180.8% avg upside
5 analysts
|
— | +25.5% |
|
XGN
Exagen
|
May 12, 2026 | BUY |
Strong Buy
+185.8% avg upside
10 analysts
|
$8.00
91.77% Upside
|
-1.9% |
|
PSNL
Personalis
|
May 11, 2026 | BUY |
Strong Buy
-17.9% avg upside
11 analysts
|
$11.00
26.21% Downside
|
+143.4% |
|
BLLN
BillionToOne, Inc. Class A
|
May 07, 2026 | BUY |
Strong Buy
-0.6% avg upside
8 analysts
|
$130.00
5.46% Upside
|
+34.4% |
|
ADPT
Adaptive Biotechnologies
|
May 06, 2026 | BUY |
Strong Buy
+0.1% avg upside
14 analysts
|
$22.00
3.88% Upside
|
+46.0% |
|
WGS
GeneDx Holdings
|
May 05, 2026 | BUY |
Strong Buy
+16.0% avg upside
9 analysts
|
$90.00
46.71% Upside
|
+82.9% |
|
CERS
Cerus
|
May 01, 2026 | BUY |
Strong Buy
+75.8% avg upside
10 analysts
|
$4.00
36.49% Upside
|
+3.7% |
|
NEO
NeoGenomics
|
Apr 30, 2026 | HOLD |
Strong Buy
+10.8% avg upside
17 analysts
|
— | +52.4% |
|
CDNA
CareDx
|
Apr 29, 2026 | BUY |
Buy
+13.4% avg upside
16 analysts
|
$28.00
2.40% Downside
|
+37.1% |
|
DNA
Ginkgo Bioworks Holdings
|
Mar 12, 2026 | SELL |
Hold
-13.4% avg upside
5 analysts
|
$5.00
44.97% Downside
|
-41.4% |
|
ZTS
Zoetis
|
Feb 26, 2026 | BUY |
Buy
+70.5% avg upside
22 analysts
|
$160.00
117.13% Upside
|
-42.3% |
|
IDXX
Idexx Laboratories
|
Feb 03, 2026 | BUY |
Strong Buy
+33.0% avg upside
17 analysts
|
$800.00
48.96% Upside
|
-10.9% |
|
BNGO
BioNano Genomics
|
Aug 22, 2025 | HOLD |
Buy
+718.2% avg upside
9 analysts
|
— | -68.5% |
|
RNLXY
Renalytix
|
May 20, 2024 | BUY |
Strong Buy
+462.8% avg upside
5 analysts
|
$2.00
4.75% Upside
|
· |
|
HLTHQ
Cue Health
|
Mar 21, 2024 | HOLD |
Hold
2 analysts
|
— | -100.0% |
|
TTOO
T2 Biosystems
|
Sep 22, 2023 | HOLD |
Buy
+1145584.5% avg upside
10 analysts
|
— | · |
|
HTGMQ
HTG Molecular Diagnostics
|
Dec 06, 2019 | HOLD |
Buy
+733333233.4% avg upside
6 analysts
|
— | · |
|
QDEL
QuidelOrtho
|
Nov 17, 2019 | BUY |
Buy
+122.2% avg upside
13 analysts
|
$75.00
327.09% Upside
|
+201.7% |
|
OSUR
Orasure Technologies
|
Nov 10, 2019 | HOLD |
Buy
+99.1% avg upside
11 analysts
|
$8.00
86.04% Upside
|
+54.8% |
|
QTRX
Quanterix
|
Nov 06, 2019 | BUY |
Buy
+370.6% avg upside
8 analysts
|
$35.00
764.15% Upside
|
+157.7% |
|
LH
Labcorp Holdings
|
Oct 24, 2019 | HOLD |
Strong Buy
-5.3% avg upside
36 analysts
|
$170.00
38.52% Downside
|
+26.3% |
|
ILMN
Illumina
|
Oct 24, 2019 | HOLD |
Buy
-18.5% avg upside
30 analysts
|
$310.00
61.13% Upside
|
+2.5% |
|
DGX
Quest Diagnostics
|
Oct 22, 2019 | BUY |
Buy
-16.8% avg upside
33 analysts
|
$113.00
45.25% Downside
|
+28.2% |
|
AWHL
Aspira Women's Health
|
May 23, 2018 | HOLD |
Buy
+1325.2% avg upside
6 analysts
|
$1.00
170.35% Upside
|
+8.6% |
|
RIOT
Riot Platforms
|
Feb 09, 2016 | HOLD |
Strong Buy
+41.7% avg upside
28 analysts
|
$4.00
80.10% Downside
|
+25.7% |
|
BDX
Becton Dickinson
|
May 07, 2015 | HOLD |
Buy
+28.9% avg upside
25 analysts
|
$145.00
4.16% Downside
|
+17.5% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.